The Sapieha Lab
@psapieha
We are interested in retinal and vascular aging and how it influences neuroinflammation.
ID: 459724060
http://sapiehalab.bio 10-01-2012 00:12:30
210 Tweet
348 Takipçi
150 Takip Edilen
Congratulations to Sergio Crespo-Garcia of Université de Montréal - the latest winner of our $500 Early Career Scientist Grant! 🎉 Find out how he plans to spend his $500 grant & apply for our next grant here: ow.ly/e6q350ROz7A #lifescience #earlycareerscientist #sciencefunding #postdochelp
Arrival at the #innateimmunity Aegean Conferences in Loutraki Greece. Great group of scientists here.
Our Chief Scientist Mike Sapieha, Ph.D. joined the Drug Discovery News DDN Dialogues podcast with host Stephanie DeMarco, PhD to break down our senolytic model and #UBX1325’s recent clinical trial success in improving vision and eye health in patients with #DME. bit.ly/3VBfCf7
Congratulations to Masayuki Hata for winning the « Prix Relève étoile Jacques-Genest « ARVO Faculté de médecine CIUSSS Est Montréal BrightFocus Foundation nouvelles.umontreal.ca/article/2024/0…)
The Olympic Cauldron was lit with a burning arrow on this day at Barcelona 1992. 🔥 As archery kicks off today at #Paris2024, we're throwing back to that unforgettable moment.🏹✨ World Archery
Huge thanks to Eva Kaufmann for being a tremendous host and faculty of Queen's Health Sciences for enriching discussions.
1 month until The Longevity Summit 2024 Speakers include: Longevity Global Webb Lab @ The Buck Institute charles nduka Christin Glorioso, MD PhD🏳️🌈 Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM David Furman @EricVerdin Hanadie Yousef Jamie Justice Jesse Poganik @miRNAgirl @madcule The Sapieha Lab Parnian Lak Ronjon Nag liveforever.club/events?selecte…
Important work from the Craig E Brown lab implicating high levels of IL10 in reduced cerebral blood flow associated with cognitive decline.
The best part of research are the awesome people we get to work with. Happy Holidays from the The Sapieha Lab
Happy to share our study on the beneficial role of the innate immune system on vascular remodeling in retinal disease and potential negative impact of steroids. Masayuki Hata Université de Montréal ARVO CIHR BrightFocus Foundation American Diabetes Association ISER pnas.org/doi/10.1073/pn…
Happy to share our latest publication on the phase 2 BEHOLD trial that evaluated effects of our senolytic drug candidate UBX1325 in subjects with diabetic macular edema. #diabetes UNITY Biotechnology ARVO NEJM Evidence AAO evidence.nejm.org/doi/full/10.10…